Congenital syndromes of severe insulin resistance

Pediatric Endocrinology Reviews

Volumn 8, Issue 3, 2011, Pages 190-199

  Huang Doran, Isabel ^a   Savage, David B ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Acanthosis nigricans; Diabetes; Insulin resistance; Lipodystrophy; Obesity; Polycystic ovarian syndrome

Indexed keywords

ADIPONECTIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; FIBRIC ACID DERIVATIVE; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN RECEPTOR; LEPTIN; METFORMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT SOMATOMEDIN C; SEX HORMONE BINDING GLOBULIN;

ACANTHOSIS NIGRICANS; ADOLESCENT DISEASE; CHILDHOOD DISEASE; CLINICAL FEATURE; DIABETES MELLITUS; DIET THERAPY; DYSLIPIDEMIA; FAMILIAL PARTIAL LIPODYSTROPHY; FATTY LIVER; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GROWTH DISORDER; HUMAN; HYPERANDROGENISM; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPODYSTROPHY; REVIEW; FEMALE; GENETICS; HOMEOSTASIS; MALE; METABOLISM; MUTATION; SIGNAL TRANSDUCTION; SYNDROME;

ACANTHOSIS NIGRICANS; BLOOD GLUCOSE; FEMALE; HOMEOSTASIS; HUMANS; HYPERANDROGENISM; INSULIN; INSULIN RESISTANCE; LIPODYSTROPHY, FAMILIAL PARTIAL; MALE; MUTATION; RECEPTOR, INSULIN; SIGNAL TRANSDUCTION; SYNDROME;

EID: 79957804531     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Konrad D, Rudich S, Klip. A Insulin-mediated Regulation of Glucose Metabolism. In: Kumar S, O'Rahilly S eds. Insulin Resistance. London: John Wiley. 2005;2:63-85
2. Souren NY, Paulussen AD, Loos RJ, Gielen M, Beunen G, Fagard R, Derom C, Vlietinck R, Zeegers MP. Anthropometry, carbohydrate and lipid metabolism in the East Flanders Prospective Twin Survey: heritabilities. Diabetologia 2007;50:2107-2116 (Pubitemid 47373863)
3. O'Rahilly S Human obesity and insulin resistance: lessons from experiments of nature. Biochem Soc Trans 2007;35:33-36
4. Kahn CR, Flier JS, Bar RS, Archer JA, Gorden P, Martin MM, Roth J. The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man. N Engl J Med 1976;294:739-745
5. Garg A. Acquired and inherited lipodystrophies. N Engl J Med 2004;350:1220-1234 (Pubitemid 38339366)
6. Gorden P, Collier E, Roach P Autoimmune mechanisms of insulin resistance and hypoglycemia. In: Moley DE ed. Insulin resistance. London: John Wiley1993;123-142
7. Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine (Baltimore) 2009;88:141-153
8. Kahn SE The importance of the beta-cell in the pathogenesis of type 2 diabetes mellitus. Am J Med 108 Suppl 2000;6a:2S-8S
9. Agostini M, Schoenmakers E, Mitchell C, Szatmari I, Savage D, Smith A, Rajanayagam O, Semple R, Luan J, Bath L, Zalin A, Labib M, Kumar S, Simpson H, Blom D, Marais D, Schwabe J, Barroso I, Trembath R, Wareham N, Nagy L, Gurnell M, O'Rahilly S, Chatterjee K 2006 Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance. Cell metabolism 2006;4:303-311 (Pubitemid 44430916)
10. George S, Rochford JJ, Wolfrum C, Gray SL, Schinner S, Wilson JC, Soos MA, Murgatroyd PR, Williams RM, Acerini CL, Dunger DB, Barford D, Umpleby AM, Wareham NJ, Davies HA, Schafer AJ, Stoffel M, O'Rahilly S, Barroso I. A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science 2004;304:1325-1328 (Pubitemid 38697429)
11. Hojlund K, Hansen T, Lajer M, Henriksen JE, Levin K, Lindholm J, Pedersen O, Beck-Nielsen H A novel syndrome of autosomal-dominant hyperinsulinemic hypoglycemia linked to a mutation in the human insulin receptor gene. Diabetes 2004;53:1592-1598 (Pubitemid 38697674)
12. Huang Z, Li Y, Tang T, Xu W, Liao Z, Yao B, Hu G, Weng Hyperinsulinaemic hypoglycaemia associated with a heterozygous missense mutation of R1174W in the insulin receptor (IR) gene. Clin Endocrinol (Oxf) 2009;71:659-665
13. Kotronen A, Juurinen L, Tiikkainen M, Vehkavaara S, Yki-Jarvinen H. Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin. Resistance in type 2 diabetes. Gastroenterology 2008;135:122-130 (Pubitemid 351899009)
14. Torley D, Bellus GA, Munro CS. Genes, growth factors and acanthosis nigricans. The British journal of dermatology 2002;147:1096-1101 (Pubitemid 36963014)
15. Ellis DL, Kafka SP, Chow JC, Nanney LB, Inman WH, McCadden ME, King LE, Jr. Melanoma, growth factors, acanthosis nigricans, the sign of Leser-Trelat, and multiple acrochordons. A possible role for alpha-transforming growth factor in cutaneous paraneoplastic syndromes. N Engl J Med 1987;317:1582-1587 (Pubitemid 18014385)
16. Hermanns-Le T, Scheen A, Pierard GE Acanthosis nigricans associated with insulin resistance: pathophysiology and management. American journal of clinical dermatology 2004;5:199-203 (Pubitemid 38901549)
17. Nestler JE, Jakubowicz DJ. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 1996;335:617-623 (Pubitemid 26277951)
18. Dunaif A, Hoffman AR, Scully RE, Flier JS, Longcope C, Levy LJ, Crowtey WF, Jr. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization. Obstet Gynecol 1985;66:545-552 (Pubitemid 16236444)
19. Srinivasan S, Waters MJ, Rowtand JE, Baxter RC, Verge CF. Hyperinsulinism and overgrowth without obesity. Arch Dis Child 2003;88:332-334 (Pubitemid 36398974)
20. Flier JS, Moller DE, Moses AC, O'Rahilly S, Chaiken RL, Grigorescu F, Elahi D, Kahn BB, Weinreb JE, Eastman R. Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance. J Clin Endocrinol Metab 1993;76:1533-1541 (Pubitemid 23164374)
21. O'Rahilly S, Moller DE. Mutant insulin receptors in syndromes of insulin resistance. Clin Endocrinol (Oxf) 1992;36:121-132
22. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, Taylor SI. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988;240:787-790
23. Donohue WL, Uchida I. Leprechaunism: a euphemism for a rare familial disorder. J Pediatr 1954;45:505-519
24. Pedersen O. Genetics of insulin resistance. Exp Clin Endocrinol Diabetes 1999;107:113-118 (Pubitemid 29179277)
25. Dash S, Sano H, Rochford JJ, Semple RK, Yeo G, Hyden CS, Soos MA, Clark J, Rodin A, Langenberg C, Druet C, Fawcett KA, Tung YC, Wareham NJ, Barroso I, Lienhard GE, O'Rahilly S, Savage DB. A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia. Proc Natl Acad Sci USA 2009;106:9350-9355
26. Tershakovec AM, Frank I, Rader D. HIV-related lipodystrophy and related factors. Atherosclerosis 2004;174:1-10 (Pubitemid 38595433)
27. Shulman GI. Cellular mechanisms of insulin resistance. J Clin Invest 2000;106:171-176 (Pubitemid 30483118)
28. Danforth E, Jr. Failure of adipocyte differentiation causes type II diabetes mellitus? Nat Genet 2000;26:13
29. Savage DB, Petersen KF, Shulman GI. Disordered lipid metabolism and the pathogenesis of insulin resistance. Physiol Rev 2007;87:507-520 (Pubitemid 47084679)
30. Virtue S, Vidal-Puig A. It's not how fat you are, it's what you do with it that counts. PLoS Biol 2008;6:e237
31. Seip M, Trygstad O Generalized lipodystrophy, congenital and acquired (lipoatrophy). Acta Paediatr Suppl 1996;413:2-28 (Pubitemid 26189575)
32. Garg A, Fleckenstein JL, Peshock RM, Grundy SM 1992 Peculiar distribution of adipose tissue in patients with congenital generalized lipodystrophy. J Clin Endocrinol Metab. 75:358-361
33. Garg A, Peshock RM, Fleckenstein JL. Adipose tissue distribution pattern in patients with familial partial lipodystrophy (Dunnigan variety). J Clin Endocrinol Metab 1999;84:170-174 (Pubitemid 29036696)
34. Magre J, Delepine M, Khallouf E, Gedde-Dahl T, Jr., Van Maldergem L, Sobel E, Papp J, Meier M, Megarbane A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F, Navarro J, Nivelon-Chevalier A, Polak M, Robert JJ, Tric P, Tubiana-Rufi N, Vigouroux C, Weissenbach J, Savasta S, Maassen JA, Trygstad O, Bogalho P, Freitas P, Medina JL, Bonnicci F, Joffe BI, Loyson G, Panz VR, Raal FJ, O'Rahilly S, Stephenson T, Kahn CR, Lathrop M, Capeau J. Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13. Nat Genet 2001;28:365-370 (Pubitemid 32702427)
35. Agarwal AK, Arioglu E, De Almeida S, Akkoc N, Taylor SI, Bowcock AM, Barnes RI, Garg A 2002 AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34. Nat Genet 31:21-23
36. Kim CA, Delepine M, Boutet E, El Mourabit H, Le Lay S, Meier M, Nemani M, Bridel E, Leite CC, Bertola DR, Semple RK, O'Rahilly S, Dugail I, Capeau J, Lathrop M, Magre J 2008 Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy. J Clin Endocrinol Metab 93:1129-1134 (Pubitemid 351540679)
37. Hayashi YK, Matsuda C, Ogawa M, Goto K, Tominaga K, Mitsuhashi S, Park YE, Nonaka I, Hino-Fukuyo N, Haginoya K, Sugano H, Nishino I 2009 Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy. J Clin Invest 119:2623-2633
38. Worman HJ, Fong LG, Muchir A, Young SG. Laminopathies and the long strange trip from basic cell biology to therapy. J Clin Invest 2009;119:1825-1836
39. Savage DB, Soos MA, Powlson A, O'Rahilly S, McFarlane I, Halsall DJ, Barroso I, Thomas EL, Bell JD, Scobie I, Belchetz PE, Kelly WF, Schafer AJ. Familial partial lipodystrophy associated with compound heterozygosity for novel mutations in the LMNA gene. Diabetologia 2004;47:753-756 (Pubitemid 38658379)
40. Cao H, Hegete RA. Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy. Hum Mol Genet 2000;9:109-112 (Pubitemid 30145295)
41. Agarwal AK, Fryns JP, Auchus RJ, Garg A Zinc metalloproteinase, ZMPSTE24, is mutated in mandibuloacral dysplasia. Hum Mol Genet 2003;12:1995-2001 (Pubitemid 37038808)
42. Savage DB, Tan GD, Acerini CL, Jebb SA, Agostini M, Gurnell M, Williams RL, Umpteby AM, Thomas EL, Bell JD, Dixon AK, Dunne F, Boiani R, Cinti S, Vidal-Puig A, Karpe F, Chatterjee VK, O'Rahilly S. Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma. Diabetes 2003;52:910-917 (Pubitemid 36384259)
43. Rubio-Cabezas O, Puri V, Murano I, Saudek V, Semple RK, Dash S, Hyden CS, Bottomley W, Vigouroux C, Magre J, Raymond-Barker P, Murgatroyd PR, Chawta A, Skepper JN, Chatterjee VK, Suliman S, Patch AM, Agarwal AK, Garg A, Barroso I, Cinti S, Czech MP, Argente J, O'Rahilly S, Savage DB Partial lipodystrophy and insulin resistant diabetes in a patient with a homozygous nonsense mutation in CIDEC. EMBO Mol Med 2009;1:280-287
44. Savage DB, Agostini M, Barroso I, Gurnell M, Luan J, Meirhaeghe A, Harding AH, Ihrke G, Rajanayagam O, Soos MA, George S, Berger D, Thomas EL, Bell JD, Meeran K, Ross RJ, Vidal-Puig A, Wareham NJ, O'Rahilly S, Chatterjee VK, Schafer AJ Digenic inheritance of severe insulin resistance in a human pedigree. Nat Genet 2002;31:379-384 (Pubitemid 35154446)
45. Beales PL, Farooqi IS, O'Rahilly S 2009 Genetics of Obesity Syndromes. New York, Oxford Univeristy Press
46. Minton JA, Owen KR, Ricketts CJ, Crabtree N, Shaikh G, Ehtisham S, Porter JR, Carey C, Hodge D, Paisey R, Walker M, Barrett TG 2006 Syndromic obesity and diabetes: changes in body composition with age and mutation analysis of ALMS1 in 12 United Kingdom kindreds with Alstrom syndrome. J Clin Endocrinol Metab 91:3110-3116 (Pubitemid 44271765)
47. Semple RK, Cochran EK, Soos MA, Burling KA, Savage DB, Gorden P, O'Rahilly S 2008 Plasma adiponectin as a marker of insulin receptor dysfunction: clinical utility in severe insulin resistance. Diabetes Care 31:977-979
48. Semple RK, Halberg NH, Burling K, Soos MA, Schraw T, Luan J, Cochran EK, Dunger DB, Wareham NJ, Scherer PE, Gorden P, O'Rahilly S 2007 Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56:1712-1717 (Pubitemid 46842611)
49. Semple RK, Soos MA, Luan J, Mitchell CS, Wilson JC, Gurnell M, Cochran EK, Gorden P, Chatterjee VK, Wareham NJ, O'Rahilly S 2006 Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91:3219-3223 (Pubitemid 44271779)
50. Semple RK, Sleigh A, Murgatroyd PR, Adams CA, Bluck L, Jackson S, Vottero A, Kanabar D, Charlton-Menys V, Durrington P, Soos MA, Carpenter TA, Lomas DJ, Cochran EK, Gorden P, O'Rahilly S, Savage DB 2009 Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. J Clin Invest 119:315-322
51. Semple RK, Savage DB, Hatsall DJ, O'Rahilly S 2010 Syndromes of Severe Insulin Resistance and/or Lipodystrophy. In: Weiss RE, Refetoff S eds. Genetic Diagnosis of Endocrine Disorders: Elsevier
52. Nakae J, Kato M, Murashita M, Shinohara N, Tajima T, Fujieda K 1998 Long-term effect of recombinant human insulin-like growth factor 1 on metabolic and growth control in a patient with leprechaunism. J Clin Endocrinol Metab 83:542-549 (Pubitemid 28496537)
53. Quin JD, Fisher BM, Paterson KR, Inoue A, Beastalt GH, MacCuish AC 1990 Acute response to recombinant insulin-like growth factor 1 in a patient with Mendenhall's syndrome. N Engl J Med 323:1425-1426
54. Regan FM, Williams RM, McDonald A, Umpleby AM, Acerini CL, O'Rahilly S, Hovorka R, Semple RK, Dunger DB Treatment with recombinant human insulin-like growth factor (rhlGF)-1/rhlGF binding protein-3 complex improves metabolic control in subjects with severe insulin resistance. J Clin Endocrinol Metab 95:2113-2122
55. Savage DB, O'Rahilly S 2009 Leptin therapy in lipodystrophy. Diabetologia 53:7-9
56. Beltrand J, Beregszaszi M, Chevenne D, Sebag G, De Kerdanet M, Huet F, Polak M, Tubiana-Rufi N, Lacombe D, De Paoli AM, Levy-Marchal C Metabolic correction induced by leptin replacement treatment in young children with Berardinelli-Seip congenital lipoatrophy. Pediatrics 2007;120:e291-296 (Pubitemid 47219478)
57. Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI 2002 Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 2002;109:1345-1350 (Pubitemid 34546899)
58. Savage DB, O'Rahilly S 2002 Leptin: a novel therapeutic role in lipodystrophy. J Clin Invest 109:1285-1286 (Pubitemid 34546891)